Literature DB >> 15887282

Immune abnormalities are a frequent manifestation of Kabuki syndrome.

Jodi D Hoffman1, Karen L Ciprero, Kathleen E Sullivan, Paige B Kaplan, Donna M McDonald-McGinn, Elaine H Zackai, Jeffrey E Ming.   

Abstract

Kabuki syndrome (KS) is associated with multiple organ system involvement. Characteristic features include long palpebral fissures with everted lower lids, prominent ears, skeletal abnormalities, mental retardation, and short stature. An increased incidence of infection has been reported in KS, and a few patients have been noted to have immune defects. However, the frequency and severity of the immune deficiency has not been clearly defined. Immunologic evaluation of 19 consecutive individuals with KS was performed at The Children's Hospital of Philadelphia. Decreased IgA levels were noted in 15/19 individuals (79%), 2 of whom had undetectable levels. Eight patients (42%) also had low total IgG levels. Specific IgG subclass abnormalities were found in 6 of 13 patients evaluated. IgM levels were less frequently decreased. One patient failed to generate anti-tetanus antibodies despite immunization. This study suggests that hypogammaglobulinemia is a frequent finding in children with KS. The pattern of antibody abnormalities seen in children with KS resembles common variable immune deficiency (CVID). Due to this increased susceptibility to infection, children with KS should have immunologic evaluations at the time of diagnosis in order to reduce preventable morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887282     DOI: 10.1002/ajmg.a.30722

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 2.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

3.  Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab.

Authors:  Brian Kerr; Philip Murphy; John Quinn
Journal:  Int J Hematol       Date:  2017-01-30       Impact factor: 2.490

Review 4.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

5.  RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.

Authors:  Ziwei Yin; Maki Kobayashi; Wenjun Hu; Koichi Higashi; Nasim A Begum; Ken Kurokawa; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

6.  Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.

Authors:  Yuka Torii; Hiroshi Yagasaki; Hidenori Tanaka; Seiji Mizuno; Nobuhiro Nishio; Hideki Muramatsu; Asahito Hama; Yoshiyuki Takahashi; Seiji Kojima
Journal:  Int J Hematol       Date:  2009-08-07       Impact factor: 2.490

Review 7.  Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination.

Authors:  Jeremy A Daniel; André Nussenzweig
Journal:  Biochim Biophys Acta       Date:  2012-02-12

Review 8.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

9.  The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.

Authors:  Ana Ortega-Molina; Isaac W Boss; Andres Canela; Heng Pan; Yanwen Jiang; Chunying Zhao; Man Jiang; Deqing Hu; Xabier Agirre; Itamar Niesvizky; Ji-Eun Lee; Hua-Tang Chen; Daisuke Ennishi; David W Scott; Anja Mottok; Christoffer Hother; Shichong Liu; Xing-Jun Cao; Wayne Tam; Rita Shaknovich; Benjamin A Garcia; Randy D Gascoyne; Kai Ge; Ali Shilatifard; Olivier Elemento; Andre Nussenzweig; Ari M Melnick; Hans-Guido Wendel
Journal:  Nat Med       Date:  2015-09-14       Impact factor: 53.440

Review 10.  Epigenetic control of the immune system: a lesson from Kabuki syndrome.

Authors:  Stefano Stagi; Anna Virginia Gulino; Elisabetta Lapi; Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.